CC
TNYA icon

Casdin Capital’s Tenaya Therapeutics TNYA Stock Holding History

Casdin Capital’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$268K Hold
361,969
– – 0.01% 43
2026
Q1 		$251K Hold
361,969
– – 0.02% 39
2025
Q4 		$258K Hold
361,969
– – 0.02% 38
2025
Q3 		$586K Hold
361,969
– – 0.05% 31
2025
Q2 		$221K Sell
361,969
-6,371,002
-95% -$3.24M 0.02% 33
2025
Q1 		$3.84M Hold
6,732,971
– – 0.31% 29
2024
Q4 		$9.63M Hold
6,732,971
– – 0.64% 22
2024
Q3 		$13M Hold
6,732,971
– – 0.87% 20
2024
Q2 		$20.9M Hold
6,732,971
– – 1.59% 15
2024
Q1 		$35.2M Buy
6,732,971
+351,594
+6% +$1.68M 2.62% 12
2023
Q4 		$20.7M Hold
6,381,377
– – 2.03% 16
2023
Q3 		$16.3M Hold
6,381,377
– – 1.8% 16
2023
Q2 		$37.5M Buy
6,381,377
+302,517
+5% +$1.76M 3.27% 13
2023
Q1 		$17.3M Hold
6,078,860
– – 1.43% 22
2022
Q4 		$12.2M Buy
6,078,860
+2,492,042
+69% +$6.08M 0.95% 28
2022
Q3 		$10.4M Hold
3,586,818
– – 0.68% 24
2022
Q2 		$20.2M Hold
3,586,818
– – 1.71% 17
2022
Q1 		$42.3M Hold
3,586,818
– – 1.89% 22
2021
Q4 		$68M Hold
3,586,818
– – 1.92% 17
2021
Q3 		$74.1M Buy
+3,586,818
New +$77.1M 1.84% 22

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Casdin Capital's TNYA Position: Q2 2026 in Review

Casdin Capital held its Tenaya Therapeutics (TNYA) position steady in Q2 2026 at 361,969 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #43.

Casdin Capital first reported a position in TNYA in Q3 2021 and has held it in 20 quarters since. The position peaked at $74.1M in Q3 2021. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Casdin Capital held 361,969 shares of Tenaya Therapeutics worth $268K as of Q2 2026.
  • Casdin Capital left its Tenaya Therapeutics share count unchanged in Q2 2026.
  • Tenaya Therapeutics made up 0.01% of Casdin Capital's portfolio in Q2 2026, its #43 holding.
  • Casdin Capital first reported a position in Tenaya Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Casdin Capital's Tenaya Therapeutics position peaked at $74.1M in Q3 2021.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Casdin Capital's 13F filing for Q2 2026, filed 14 Aug 2026.